Summary
The product Oxydrol 50mg Injection, manufactured by PHARM400, underwent independent testing to verify its authenticity and potency. The sample, submitted by the Manufacturer Pharmaqo Labs mrp@vitamins.to, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxymetholone, with a concentration of 48.32 mg/ml, slightly below the labeled claim of 50 mg/ml by 3.36%.
The testing process began on 1 February 2024, with the analysis completed on the same day. The batch number was not provided, and the sample description lacked detailed information. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: Oxydrol 50mg Injection
- Active Ingredient: Oxymetholone
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #38194
- Testing Ordered: 1 February 2024
- Sample Received: 1 February 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 50 mg/ml (as stated on the label)
- Measured Concentration: 48.32 mg/ml
- Accuracy: 96.64% (3.36% below the label claim)
- Variance: 3.36
Verification Details
- Verification URL: https://janoshik.com/tests/38194_CTBYWVGDHLI4
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product. While the results confirm accurate dosing, manufacturer-submitted testing may involve inherent biases. Independent validation through third-party testing across multiple batches is recommended to ensure product consistency and reliability.
Conclusion
The analysis confirms that Oxydrol 50mg Injection is slightly underdosed, with a measured concentration of 48.32 mg/ml. This result reflects the need for additional testing and detailed sample information to ensure product consistency and reliability. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
